Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-13-023

Research Answers to NCIs Provocative Questions - Group D (R21)

Closed on June 20, 2014.

Posted
September 30, 2013
Close date
June 20, 2014
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
2
2 new
Median first-year cost
$211,084
$422,168 in all
Institutions
2
2 contact PIs

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. BOSTON UNIVERSITY MEDICAL CAMPUS1
  2. UNIVERSITY OF ILLINOIS AT CHICAGO1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 GRB-S (J1))2
2 awards under RFA-CA-13-023 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015IGPR-1 in colon cancer chemotherapy1R21CA193958-01Rahimi, NaderBOSTON UNIVERSITY MEDICAL CAMPUS, MAFirst-year cost $213,629Study section ZCA1
FY2015Cytoplasmic FOXM1 contributes to the higher complete remission and longer overall survival of AML patients after chemotherapy1R21CA194608-01Gartel, Andrei LUNIVERSITY OF ILLINOIS AT CHICAGO, ILFirst-year cost $208,539Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-21-0.3.10. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.